Disease Areas
News on disease research and therapeutic development trends in precision medicine.
Personalis, Tempus Partner to Commercialize Blood-Based Minimal Residual Disease Test
Tempus will market Personalis' NeXT Personal Dx liquid biopsy while Personalis completes its clinical validation in more indications.
Quest Diagnostics, Scipher Medicine Collaborate on Rheumatoid Arthritis Test
Quest will provide RNA extraction and sequencing services for Scipher's PrismRA test, a blood-based molecular test for predicting patient response to TNF inhibitors.
Autolus Seeks FDA Approval for CAR T-Cell Therapy in B-Cell Acute Lymphoblastic Leukemia
The firm's supplemental biologics license application is based on encouraging data from a Phase II trial in more than 100 patients.
Vertex Nets European Label Expansion for Kaftrio Combo in Younger Cystic Fibrosis Patients
Vertex is also seeking to expand the Kaftrio-Kalydeco combination to cystic fibrosis patients with non-F508del Kaftrio-responsive CFTR mutations.
FDA Grants Abeona Therapeutics Priority Review for Wound Healing Cell Therapy Application
The agency will review data submitted by the firm from two trials showing pz-cel's ability to heal wounds for those with COL7A1-mutated recessive dystrophic epidermolysis bullosa.